BANCROFT ROBERT E. (PRESIDENT & CEO) received a stock award from AEON BIOPHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 5/16/2025ACC: 0001610717-25-000120
DirectorOfficer· PRESIDENT & CEO
Since Feb 2026
+177.10K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
177.10K acquired
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
+177.10K
Price / share
—
Trade value
—
% of position
New position
5/14/2025
0.00→177.10K
Total
Net shares
+177.10K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 5/14/2025 | A · Award | +177.10K | — | — | New position | 0.00 | 177.10K |
| Total | +177.10K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported